Paloma Partners Management CO Laboratory Corp Of America Holdings Call Options Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$211.93 - $241.33 $699,369 - $796,389	-3,300 Reduced 52.38%	3,000 $723,000
Q1 2023 May 15, 2023	BUY	$213.32 - $257.83 $149,324 - $180,481	700 Added 12.5%	6,300 $1.45 Million
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $1.14 Million - $1.39 Million	5,600 New	5,600 $1.32 Million
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $427,720 - $555,740	-2,000 Reduced 23.81%	6,400 $1.5 Million
Q4 2020 Feb 16, 2021	BUY	$186.91 - $214.42 $1.55 Million - $1.78 Million	8,300 Added 8300.0%	8,400 $1.71 Million
Q2 2020 Aug 14, 2020	BUY	$113.31 - $182.44 $11,331 - $18,244	100 New	100 $17,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.